Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer

por Reyes, Roxana, Reguart, Noemi
Publicado 2021

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

por Reguart, Noemí, Cardona, Andrés Felipe, Rosell, Rafael
Publicado 2010

PD-L1 expression testing in non-small cell lung cancer

por Teixidó, Cristina, Vilariño, Noelia, Reyes, Roxana, Reguart, Noemí
Publicado 2018

Epigenetic Reprogramming of Tumor-Associated Fibroblasts in Lung Cancer: Therapeutic Opportunities

por Alcaraz, Jordi, Ikemori, Rafael, Llorente, Alejandro, Díaz-Valdivia, Natalia, Reguart, Noemí, Vizoso, Miguel
Publicado 2021

Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

por Batson, Sarah, Mitchell, Stephen A, Windisch, Ricarda, Damonte, Elisabetta, Munk, Veronica C, Reguart, Noemi
Publicado 2017

PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement

por Isla, Dolores, Sánchez, Alfredo, Casal, Joaquín, Cobo, Manuel, Majem, Margarita, Reguart, Noemi, Zugazagoitia, Jon, Bernabé, Reyes
Publicado 2023

Integrin-Specific Mechanoresponses to Compression and Extension Probed by Cylindrical Flat-Ended AFM Tips in Lung Cells

por Acerbi, Irene, Luque, Tomás, Giménez, Alícia, Puig, Marta, Reguart, Noemi, Farré, Ramon, Navajas, Daniel, Alcaraz, Jordi
Publicado 2012

A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC

por Aya, Francisco, Benegas, Mariana, Viñolas, Nuria, Reyes, Roxana, Vollmer, Ivan, Arcocha, Ainara, Sánchez, Marcelo, Reguart, Noemi
Publicado 2021

Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients

por Marin, Elba, Reyes, Roxana, Arcocha, Ainara, Viñolas, Nuria, Mezquita, Laura, Gonzalvo, Elena, Saez de Gordoa, Karmele, Jares, Pedro, Reguart, Noemi, Teixido, Cristina
Publicado 2020

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions

por González de Aledo-Castillo, José Manuel, Serhir-Sgheiri, Samira, Calbet-Llopart, Neus, Arcocha, Ainara, Jares, Pedro, Reguart, Noemí, Puig-Butillé, Joan Antón
Publicado 2021

Correction to: SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022)

por García-Campelo, Rosario, Sullivan, Ivana, Arriola, Edurne, Insa, Amelia, Juan Vidal, Oscar, Cruz-Castellanos, Patricia, Morán, Teresa, Reguart, Noemí, Zugazagoitia, Jon, Dómine, Manuel
Publicado 2023

Efficacy of Wnt-1 monoclonal antibody in sarcoma cells

por Mikami, Iwao, You, Liang, He, Biao, Xu, Zhidong, Batra, Sonny, Lee, Amie Y, Mazieres, Julien, Reguart, Noemi, Uematsu, Kazutsugu, Koizumi, Kiyoshi, Jablons, David M
Publicado 2005

BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib

por Karachaliou, Niki, Arrieta, Oscar, Giménez-Capitán, Ana, Aldeguer, Erika, Drozdowskyj, Ana, Chaib, Imane, Reguart, Noemí, Garcia-Campelo, Rosario, Chen, Jing-Hua, Molina-Vila, Miguel Angel, Rosell, Rafael
Publicado 2020

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

por Enrico, Diego, Tsou, Florencia, Catani, Greta, Pupareli, Carmen, Girotti, María Romina, Ulloa Alvarez, David Esteban, Waisberg, Federico, Rodríguez, Andrés, Reyes, Roxana, Chacón, Matías, Reguart, Noemí, Martín, Claudio
Publicado 2022

Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review

por Zhang, Zhe, Yang, Sen, Ma, Yanfang, Zhou, Hanqiong, Wu, Xuan, Han, Jing, Hou, Jiabao, Hao, Lidan, Spicer, Jonathan D., Koh, Young Wha, Provencio, Mariano, Reguart, Noemi, Mitsudomi, Tetsuya, Wang, Qiming
Publicado 2021

3D collagen migration patterns reveal a SMAD3-dependent and TGF-β1-independent mechanism of recruitment for tumour-associated fibroblasts in lung adenocarcinoma

por Juste-Lanas, Yago, Díaz-Valdivia, Natalia, Llorente, Alejandro, Ikemori, Rafael, Bernardo, Alejandro, Arshakyan, Marselina, Borau, Carlos, Ramírez, Josep, Ruffinelli, José Carlos, Nadal, Ernest, Reguart, Noemí, García-Aznar, José M., Alcaraz, Jordi
Publicado 2022

Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung

por Lugo, Roberto, Gabasa, Marta, Andriani, Francesca, Puig, Marta, Facchinetti, Federica, Ramírez, Josep, Gómez-Caro, Abel, Pastorino, Ugo, Fuster, Gemma, Almendros, Isaac, Gascón, Pere, Davalos, Albert, Reguart, Noemí, Roz, Luca, Alcaraz, Jordi
Publicado 2016

Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice

por González de Aledo-Castillo, José Manuel, Arcocha, Ainara, Victoria, Iván, Martinez-Puchol, Ana Isabel, Sánchez, Cristina, Jares, Pedro, Rodríguez, Gabriel Felipe, Viñolas, Núria, Reyes, Roxana, Reguart, Noemí, Puig-Butillé, Joan Antón
Publicado 2021

ROS1 copy number alterations are frequent in non-small cell lung cancer

por Clavé, Sergi, Gimeno, Javier, Muñoz-Mármol, Ana M., Vidal, Joana, Reguart, Noemí, Carcereny, Enric, Pijuan, Lara, Menéndez, Sílvia, Taus, Álvaro, Mate, José Luís, Serrano, Sergio, Albanell, Joan, Espinet, Blanca, Arriola, Edurne, Salido, Marta
Publicado 2016